REFERENCES
- Hancock R, Speert D. Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and impact on treat-ment. Drug Resis. Updates 2000; 3: 247–255.
- Yetkin G, Otlu B, Cicek A, Kuzucu C, Durmaz R. Clinical, microbiologic, and epidemiologic characteristics of Pseudo-monas aeruginosa infections in a University Hospital, Malatya, Turkey. Am J Infect Cont. 2006; 34: 188–192.
- Woltera D, Smith-Molanda E, Goeringb R, Hansona N, Lister P. Multidrug resistance associated with mexXY expression in clinical isolates of Pseudomonas aeruginosa from a Texas hospital. Diagn Microbiol Infect Dis 2004; 50: 43–50.
- Aloush V, Navon-Venezia S, Seigman-Igra Y, Cabili S, Carmeli Y. Multidrug-resistant Pseudomonas aeruginosa: risk factors and clinical impact. Antimicrob Agents Chemother. 2006; 50 (1): 43–8.
- Shehabi AA, Masoud H, Maslamani FA. Common antimi-crobial resistance patterns, biotypes and serotypes found among Pseudomonas aeruginosa isolates from patient's stools and drinking water sources in Jordan. J Chemother 2005; 17 (2): 179–83.
- Forbes B, Sahm D, Weissfeld A. Bailey & Scott's Diag-nostic Microbiology. 11th ed. Missouri: Mosby; 2002: 390-394.
- Wikler M, Cockerill F, Craig W, Dudley M, Eliopoulos G, Hecht D et al. Clinical and Laboratory Standards Institute: Per-formance Standards for Antimicrobial Disk Susceptibility Tests, 9th edition. Wayne, PA, Clinical and Laboratory Standards In-stitute; 2006:M2-A9.
- National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 5th edition. Approved standard M7-A4. National Committee for Clinical Laboratory Standards, Wayne, PA. 2000.
- Pseudomonas aeruginosa. Todar's Online Textbook of Bacteriology. Available at www.textbookofbacteriology.net. Last accessed on September 19th, 2008.
- Soberón-Chavez G, Lépine F, Déziel E. Production of rhamnolipids by Pseudomonas aeruginosa. Appl Microbiol Biotechnol 2005; 68: 718–725.
- Promega cooperation. Technical manual genomic DNA purification part TM0580. USA: Madison; 2006:12.
- Poirel L, Cavan L, Vahagoblu H, Nordmann P. Genetic environment and expression of the extended-spectrum I3-lacta-mase blapER_i gene in gram-negative bacteria. Antimicrob Agents Chemother 2005; 49: 1708–1713.
- Bert F, Zechovsky N. Antibiotic resistance patterns in Pseudomonas aeruginosa: an 8-year surveillance study in a French hospital. Int J Antimicrob Agents. 1997; 9: 107–112.
- Cabrol S, Olliver A., Pier GB, Andremont A, Ruimy R. Transcription of quorum-sensing system genes in clinical and en-vironmental isolates of Pseudomonas aeruginosa. J Bacteriol 2003; 185: 7222–7230.
- Pagani L, Mantengoli E, Migliavacca R, Nucleo E, Pollini S, Spalla M, et al. Multifocal detection of multidrug-resistant Pseudomonas aeruginosa producing the PER-1 Extended-Spec-trum 13-Lactamase in northern Italy. J Clin Microbiol. 2004; 2523-2529.
- Nagoba BS, Deshmukh SR, Gude G, Gomashe AV, Wad-her BJ. In vitro susceptibility of Pseudomonas aeruginosa to different antibiotics. Ind J Med Microbiol. 1997; 15: 185–186.